Sales rise 23.24% to Rs 132.67 crore
Net profit of Tatva Chintan Pharma Chem rose 720.00% to Rs 9.02 crore in the quarter ended March 2026 as against Rs 1.10 crore during the previous quarter ended March 2025. Sales rose 23.24% to Rs 132.67 crore in the quarter ended March 2026 as against Rs 107.65 crore during the previous quarter ended March 2025.
For the full year,net profit rose 11742.42% to Rs 39.08 crore in the year ended March 2026 as against Rs 0.33 crore during the previous year ended March 2025. Sales rose 35.45% to Rs 496.30 crore in the year ended March 2026 as against Rs 366.42 crore during the previous year ended March 2025.
ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.Sales132.67107.65 23 496.30366.42 35 OPM %20.007.35 –18.007.05 – PBDT24.728.82 180 90.0128.11 220 PBT14.971.56 860 53.170.46 11459 NP9.021.10 720 39.080.33 11742
Powered by Capital Market – Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
First Published: May 16 2026 | 5:16 PM IST